Nadine Tschumi

Viral suppression after transition from nonnucleoside reverse transcriptase inhibitor‐ to dolutegravir‐based antiretroviral therapy: A prospective cohort study in Lesotho (DO‐REAL study)

Jennifer Anne Brown, Bienvenu Lengo Nsakala, Kuena Mokhele et al. · HIV Medicine · 2021 · 36 citations · Full text

Emergence of Acquired Dolutegravir Resistance in Treatment-experienced People With HIV in Lesotho

Nadine Tschumi, Blaise Lukau, Katleho Tlali et al. · Clinical Infectious Diseases · 2024 · 26 citations · Full text

Two-Year Outcomes of Treatment-Experienced Adults After Programmatic Transitioning to Dolutegravir: Longitudinal Data From the VICONEL Human Immunodeficiency Virus Cohort in Lesotho

Nadine Tschumi, Malebanye Lerotholi, Lipontso Motaboli et al. · Clinical Infectious Diseases · 2023 · 17 citations · Full text

Assessment of a viral load result-triggered automated differentiated service delivery model for people taking ART in Lesotho (the VITAL study): Study protocol of a cluster-randomized trial

Nadine Tschumi, Malebanye Lerotholi, Mathebe Kopo et al. · PLoS ONE · 2022 · 15 citations · Full text

Effectiveness of a peer educator-coordinated preference-based differentiated service delivery model on viral suppression among young people living with HIV in Lesotho: The PEBRA cluster-randomized trial

Mathebe Kopo, Thabo Ishmael Lejone, Nadine Tschumi et al. · PLoS Medicine · 2023 · 15 citations · Full text